Skip to main content
SpringerLink
Log in

Monitoring Blood Pressure in the Office

  • Chapter
Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics

Part of the book series: Clinical Hypertension and Vascular Diseases ((CHVD))

  • 1514 Accesses

Abstract

Manual blood pressure (BP) measurement with the mercury sphygmomanometer is no longer the preferred method for evaluating a patient’s BP status in clinical practice. Mercury is now considered to be an environmental hazard and manual BP is subject to observer error and bias in addition to patient-related factors such as anxiety. Instead, most guidelines now recommend electronic oscillometric sphygmomanometers. Semi-automated electronic sphygmomanometers which are generally modifications of home BP recorders correct some of the problems associated with manual BP measurement but readings are still higher than the awake ambulatory and home BP. Fully automated sphygmomanometers which record multiple BP readings with the patient resting quietly alone provide a more accurate office BP with mean readings being similar to home and ambulatory BP.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pickering G. High blood pressure. London: J&A Churchill; 1968.

    Google Scholar 

  2. Mancia G, Fagard R, Krzysztof N, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension. J Hypertens. 2013;31:1281–357.

    Article  PubMed  CAS  Google Scholar 

  3. Weber ME, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community – a statement of the American Society of Hypertension and the International Society of Hypertension. J Hypertens. 2014;32:3–15.

    Article  PubMed  CAS  Google Scholar 

  4. Scientific Committee on Emerging and Newly Identified Health Risks. Mercury sphygmomanometers in healthcare and the feasibility of alternatives. SCENIHR, 2009. (http://ec.europa.eu/health/scientific_committees/emerging/scenihr_09-13/opinions_en.htm)

  5. Myers MG. Eliminating the human factor in office blood pressure measurement. J Clin Hypertens. 2014;16:83–6.

    Article  Google Scholar 

  6. Mion D, Pierin AMG. How accurate are sphygmomanometers. J Hum Hypertens. 1981;12:245–8.

    Article  Google Scholar 

  7. O’Brien E, Mee F, Atkins N, O’Malley K. Inaccuracy of the Hawksley random zero sphygmomanometer. Lancet. 1990;336:1465–8.

    Article  PubMed  Google Scholar 

  8. Graves JW, Tibor M, Murtagh B, Klein L, Sheps SG. The Accoson Greenlight 300, the first non-automated mercury-free blood pressure measurement device to pass International Protocol for blood pressure measuring devices in adults. Blood Press Monit. 2004;9:13–7.

    Article  PubMed  Google Scholar 

  9. Dorigatti F, Bonso E, Zanier A, Palatini P. Validation of Heine Gamma G7 (G5) and XXL-LF aneroid devices for blood pressure measurement. Blood Press Monit 2007;12:29-33.

    Google Scholar 

  10. Tasker F, De Greeff A, Shennan AH. Development and validation of a blinded hybrid device according to the European Hypertension Society protocol: Nissei DM-3000. J Hum Hypertens. 2010;24:609–16.

    Article  PubMed  CAS  Google Scholar 

  11. Tasker F, de Greff A, Liu B, Shennan AH. Validation of a non-mercury ascultatory device according to the European Society of Hypertension protocol: Rosssmax Mandaus II. Blood Press Monit. 2009;14:121–4.

    Article  PubMed  Google Scholar 

  12. Reinders A, Jones C, Cuckson A, Shennan A. The Maxi Stabil 3: Validation of an aneroid device according to a modified British Hypertension Society protocol. Blood Press Monit. 2003;8:83–9.

    Article  PubMed  Google Scholar 

  13. Myers MG. The great myth of office blood pressure measurement. J Hypertens. 2012;30:1894–8.

    Article  PubMed  CAS  Google Scholar 

  14. Lynch JJ, Long JM, Thomas SA, Malinow KL, Katcher AH. The effects of talking on blood pressure of hypertensive and normotensive individuals. Psychosom Med. 1981;43:25–32.

    Article  PubMed  CAS  Google Scholar 

  15. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals Part 1: blood pressure measurement in humans a statement for professionals from the subcommittee of Professional and Public Education of the AM Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45:142–61.

    Article  PubMed  CAS  Google Scholar 

  16. Parati G, Stergiou GS, Asmar R, et al. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens. 2008;26:1505–26.

    Article  PubMed  CAS  Google Scholar 

  17. Myers MG. Pseudoresistant hypertension attributed to white-coat effect. Hypertension. 2012;59:532–3.

    Article  PubMed  CAS  Google Scholar 

  18. Hansen TW, Kikuya M, Thijs L, et al. Prognostic superiority of daytime ambulatory conventional blood pressure in four populations: a meta-analysis of 7030 individuals. J Hypertens. 2007;25:1554–64.

    Article  PubMed  CAS  Google Scholar 

  19. Stergiou GS, Siontis KCM, Ioannidis JPA. Home blood pressure as a cardiovascular outcome predictor. Hypertension. 2010;55:1301–3.

    Article  PubMed  CAS  Google Scholar 

  20. Dahlhof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol, adding bendroflumethazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial - Blood pressure lowering arm (ASCOT-BPLA): a multicenter randomized controlled trial. Lancet. 2005;366:895–906.

    Article  Google Scholar 

  21. Myers MG, Meglis G, Polemidiotis G. The impact of physician vs automated blood pressure readings on office-induced hypertension. J Hum Hypertens. 1997;11:491–3.

    Article  PubMed  CAS  Google Scholar 

  22. Myers MG, Valdivieso M, Chessman M, Kiss A. Can sphygmomanometers designed for self-measurement of blood pressure in the home be used in office practice? Blood Press Monit. 2010;15:300–4.

    Article  PubMed  Google Scholar 

  23. Al-Karkhi I, Al-Rubaiy R, Rosenqvist U, Falk M, Nystrom FH. Comparisons of automated blood pressures in a primary health care setting with self-measurements at the office and home using the Omron i-C10 device. Blood Press Monit 2015;20:98–103.

    Google Scholar 

  24. Stergiou GS, Efstathiou SP, Alamara CV, Mastorantonakis SE, Roussias LG. Home or self blood pressure measurement? What is the correct term? J Hypertens. 2003;21:2259–64.

    Article  PubMed  CAS  Google Scholar 

  25. Daskalopoulou SS, Rabi DM, Zarnke KB, et al. The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol 2015;31:549–568.

    Google Scholar 

  26. Beckett L, Godwin M. The BpTRU automatic blood pressure monitor compared to 24-h ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension. BMC Cardiovasc Disord. 2005;5:18.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Myers MG, Valdivieso M, Kiss A. Use of automated office blood pressure measurement to reduce the white coat response. J Hypertens. 2009;27:280–6.

    Article  PubMed  CAS  Google Scholar 

  28. Mattu GS, Perry Jr TL, Wright JM. Comparison of the oscillometric blood pressure monitor (BPM-100Beta) with the auscultatory mercury sphygmomanometer. Blood Press Monit. 2001;6:153–9.

    Article  PubMed  CAS  Google Scholar 

  29. White WB, Anwar YA. Evaluation of the overall efficacy of the Omron office digital blood pressure HEM-907 monitor in adults. Blood Press Monit. 2001;6:107–10.

    Article  PubMed  CAS  Google Scholar 

  30. Stergiou GS, Tzamouranis D, Protogerou A, Nasothimiou E, Kapralos C. Validation of the Microlife WatchBP Office professional device for office blood pressure measurement according to the International Protocol. J Hypertens. 2008;26 (Suppl 1):S481.

    Google Scholar 

  31. Yarrows SA, Patel K, Brook R. Rapid oscillometric blood pressure measurement compared to conventional oscillometric measurement. Blood Press Monit. 2001;6:145–7.

    Article  Google Scholar 

  32. Eguchi K, Kuruvilla S, Ogedegbe G, Gerin W, Schwartz JE, Pickering TG. What is the optimal interval between successive blood pressure readings using an automated oscillometric device. J Hypertens. 2009;27:1172–7.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  33. Myers MG, Valdivieso M, Kiss A, Tobe SW. Comparison of two automated sphygmomanometers for use in the office setting. Blood Press Monit. 2009;14:45–7.

    Article  PubMed  Google Scholar 

  34. Myers MG, Valdivieso M, Kiss A. Optimum frequency of automated blood pressure measurements using an automated sphygmomanometer. Blood Press Monit. 2008;13:333–8.

    Article  PubMed  Google Scholar 

  35. Greiver M, White D, Kaplan DM, Katz K, Moineddin R, Doabchian E. Where should automated blood pressure measurements be taken? Blood Press Monit. 2012;17:137–8.

    Article  PubMed  Google Scholar 

  36. Armstrong D, Matangi M, Brouillard D, Myers MG. Automated office blood pressure – being alone and not location is what matters most. Blood Press Monit 2015;20:204–208.

    Google Scholar 

  37. Chambers LW, Kaczorowski J, O’Reilly S, Ig Nagni S, Hearps SJC. Comparison of blood pressure measurements using an automated blood pressure device in community pharmacies and family physicians’ offices: a randomized controlled trial. CMAJ Open 2013.DOI:10.9778/cmajo.2013005.

  38. Myers MG, Valdivieso M, Kiss A. Consistent relationship between automated office blood pressure recorded in different settings. Blood Press Monit. 2009;14:108–11.

    Article  PubMed  Google Scholar 

  39. Myers MG, Godwin M, Dawes M, et al. Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomized parallel design controlled trial. BMJ. 2011;342:d285.

    Article  Google Scholar 

  40. Myers MG, Oh P, Reeves RA, Joyner CD. Prevalence of white coat effect in treated hypertensive patients in the community. Am J Hypertens. 1995;8:591–7.

    Article  PubMed  CAS  Google Scholar 

  41. Sedgwick P. The Hawthorne effect. BMJ. 2011;344:d8262.

    Article  Google Scholar 

  42. National Institute for Health and Clinical Excellence: Hypertension NICE Clinical Guidelines 127. National Clinical Guidelines Centre. London, UK, August, 2011.

    Google Scholar 

  43. Brown MA, Buddle ML, Martin A. Is resistant hypertension really resistant? Am J Hypertens. 2001;14:1263–9.

    Article  PubMed  CAS  Google Scholar 

  44. Graves JW, Nash C, Burger K, Bailey K, Sheps SG. Clinical decision-making in hypertension using an automated (BpTRU) measurement device. J Hum Hypertens. 2003;17:823–7.

    Article  PubMed  CAS  Google Scholar 

  45. Gustavsen PH, Hoegholm A, Bang LE, Kristensen KS. White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study. J Hum Hypertens. 2003;17:811–7.

    Article  PubMed  CAS  Google Scholar 

  46. Head GA, Mihallidou AS, Duggan KA, et al. Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ. 2010;340:1104–11.

    Article  Google Scholar 

  47. Myers MG. A proposed algorithm for diagnosing hypertension using automated office blood pressure measurement. J Hypertens. 2010;28:703–8.

    Article  PubMed  CAS  Google Scholar 

  48. Godwin M, Birtwhistle R, Delva D, et al. Manual and automated office measurements in relation to awake ambulatory blood pressure monitoring. Fam Pract. 2011;28:110–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Schulich Heart Program, Division of Cardiology, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada

    Martin G. Myers M.D.

  2. Department of Medicine, University of Toronto, Toronto, ON, Canada

    Martin G. Myers M.D.

Authors
  1. Martin G. Myers M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martin G. Myers M.D. .

Editor information

Editors and Affiliations

  1. Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, Connecticut, USA

    William B. White

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Myers, M.G. (2016). Monitoring Blood Pressure in the Office. In: White, W. (eds) Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics. Clinical Hypertension and Vascular Diseases. Humana Press, Cham. https://doi.org/10.1007/978-3-319-22771-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-22771-9_1

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-22770-2

  • Online ISBN: 978-3-319-22771-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation